Dr. David D’Alessandro, surgical director, heart transplantation and ventricular assist devices, at Massachusetts General Hospital, presents the case of a 44-year-old woman with COVID-19 who was treated using Impella 5.5 with SmartAssist.
At the time of admission patient presented with chest pain & shortness of breath.
Drs. Seth Bilazarian and Dan Raess provide an update on the management of cardiovascular complications in COVID-19 patients, with a focus on sharing emerging research and best practices.VIEW
Dr. Westenfeld speaking at the 2017 A-CURE Symposium on the clinical efficacy of left ventricular support by Impella during cardiogenic shock relieving pulmonary congestion.VIEW
Dr. Tschöpe discusses the use of prolonged Impella support to successfully bridge patients through cardiogenic shock resulting from myocarditis.
- Dr. Tschope presents clinical and Theoretical concepts regards the potential role of unloading to prevent ventricular remodeling in acute, severe viral myocarditis.
- The presentation emphasizes the potential effect of unloading may be mediated via reduced inflammatory markers with resultant improvement in cardiac function and associated biopsy evidence of reduced inflammation.
- While the presentation antedated the Coronavirus Pandemic, the principles may be applicable to a variety of viral etiologies with more experience.